News

Can-Fite is going to initiate phase I/II clinical trial with CF102 for the treatment of Hepatitis C Virus (HCV), following the approval by the Israel Ministry of Health

ImmunoVaccine (IVT) has entered into an agreement to exclusively license seven cancer antigens from Immunotope. The company said that these antigens will specifically target breast, ovarian and prostate

Biomet has reported a net loss of $749.2 million for fiscal year 2009, as compared to $1 billion for fiscal year 2008. The company has reported a net

Actavis has launched Irinotecan, a cancer drug, in the UK, France, the Netherlands, Germany, Austria and Sweden on 13 and 14 July. The patents expired on 12 and

Cystic fibrosis is a devastating hereditary chronic disease typically diagnosed in children before the age of two and is marked by mucus build-up and clogging of key organs

AmexDrug has launched two topical creams – Sponix Arthritis Muscle & Pain Relief Cream and Sponix Tired Feet & Legswhich, which provide relief on contact. Sponix Arthritis and

Noven Pharmaceuticals and Hisamitsu Pharmaceutical have entered into a merger agreement. Hisamitsu has proposed to acquire Noven for total cash consideration of approximately $428 million or $16.50 per

Quantum Immunologics (QI) has announced that the first patient in its breast cancer trial has begun to receive its dendritic cell therapy. QI is currently sponsoring and conducting

Noven has reported positive top-line results from its phase 2 clinical study evaluating Mesafem (low-dose paroxetine mesylate). It is intended for the treatment of vasomotor symptoms (hot flashes)